Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $17.38 Analyst target: $23.33 Upside: 34.23%
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.
See the full interactive analysis & chart →Informational only — not investment advice.